tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Paine, 1 are a SELL (25%), 3 are a BUY (75%).
Analyst Andrew Paine, currently employed at CLSA,
Andrew Paine’s has documented 10 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 14-Oct-2022.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Aug-2026
$262
$43.11 (19.69%)
$244
21 days ago
(15-Sep-2026)
25/32 (78.13%)
$32.56 (14.19%)
298
Buy Since 06-Feb-2024
$267
$48.11 (21.98%)
$255
1 months 5 days ago
(31-Aug-2026)
6/12 (50%)
$26.9 (11.20%)
152
Hold Since 19-Aug-2026
$230
$8 (3.60%)
1 months 17 days ago
(19-Aug-2026)
1/1 (100%)
$0.01 (0.00%)
2
Hold Since 13-Oct-2025
$215
$-3.89 (-1.78%)
$225
1 months 29 days ago
(07-Aug-2026)
4/5 (80%)
$3.67 (1.74%)
40
Hold Since 10-Jan-2025
$225
$6.11 (2.79%)
$275
1 months 29 days ago
(07-Aug-2026)
5/6 (83.33%)
$13.67 (6.47%)
51
What Year was the first public recommendation made by Andrew Paine?
